Health Care Delivery

Despite seeming to elicit more pathological complete responses (pCRs) in patients with hormone receptor–positive (HR+), HER2-negative triple-negative breast cancer (BC) receiving neoadjuvant chemotherapy, diet and exercise did not affect relative dose intensity.

Combination treatment with cabozantinib and atezolizumab did not produce any new safety signals in the treatment of those with metastatic castration-resistant prostate cancer in the phase 3 CONTACT-02 trial.

Patients with IBD-RA and depression were younger, more likely to be female, and were more frequently White compared with controls.

This retrospective study found associations between inferior nutritional index scores, malnutrition, and prognoses in patients with pulmonary arterial hypertension (PAH).

Researchers add to previous studies by refuting association between vaccines and MS flare-ups.

This study examined how inclusion of different provider specialties affected Continuity of Care Index values, year-to-year stability, and association with emergency department visits.

"We really have to work on our implicit bias, acknowledging it, understanding it, and doing the work to try to change it," Veronica Gillispie-Bell, MD, MAS, says.

Despite not reaching statistical significance, findings from DICTATE-AHF show early dapagliflozin improved decongestion and led to earlier hospital discharge for patients with acute decompensated heart failure, explained Zachary Cox, PharmD, professor at Lipscomb University College of Pharmacy.

The findings highlight the critical role that subclinical synovial proliferation plays in the progression of hemophilic arthropathy.

Millions are invested in researchers for the Cancer Moonshot initiative; some providers are charging patients for communicating online; health insurance coverage increased for half of states.

Panelists from the American College of Surgeons (ACS) and the American Urological Association spread awareness about the realities of prostate cancer, the importance of screening, and ways for men to approach their health concerns and prevention.

Lisa Rometty, CEO at Zerigo Health, discusses digital health innovations, strategies, and partnerships to improve the lives of patients living with chronic skin conditions.

Results from ATLANTE/ENGOT-ov29 show that atezolizumab did not significantly improve progression-free survival (PFS) compared with placebo plus bevacizumab for patients with platinum-sensitive ovarian cancer.

Telehealth visits were just as effective as in-person visits at managing patients initiating apremilast.

A recent CDC study revealed that reports of mistreatment and discrimination during maternity care were high among Black, Hispanic, and multiracial respondents.

Using patient priorities and converting them into treatment goals result in better primary care outcomes for Medicare patients.

Over the past 20 years, the age-adjusted mortality rate for obesity-related cardiovascular mortality increased by 415% for American Indian or Alaska Native individuals.

This article presents a descriptive review of a team-based care transformation model in a large primary care network, including core staffing, process improvement, and extended care teams.

This editorial describes several key lessons about the development of effective value-based care delivery.

FDA approves updated COVID-19 booster vaccines; low donor turnout and climate disasters result in a national blood shortage; minority patients discouraged by lack of doctor diversity.

Ryan Haumschild, PharmD, MS, MBA, director of pharmacy at Emory Winship Cancer Institute, discusses treatment options available to patients with rare diseases, as well as the challenges these patients and their pharmacists face in accessing these treatments.

An intervention for Black women living with HIV was shown to have improved perceived outcomes when incorporating a support network and when the program structure emphasized trust.

The Accountable Health Communities Model facilitates multisector coordination. Implementation science elucidated the contextual factors that facilitated the use of this model in Arizona.

Specialty pharmacy is a big area of growth, with opportunity for patients, and specialty pharmacists can help payers and insurers ensure that patients get the full value of oncology medications, noted Andre Harvin, PharmD, MS, MBA, chief pharmacy officer, Oncology Services, Cone Health Cancer Centers.

The highest proportions of patients with severe ocular impairment at baseline showed greater improvements in symptom severity on ravulizumab in comparison with placebo after 26 weeks.